School of Medicine
Showing 1-10 of 10 Results
-
Thomas Rando, MD, PhD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsOur laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.
-
Lindsey Rasmussen
Clinical Professor, Pediatrics - Critical Care
Clinical Associate Professor (By courtesy), Adult NeurologyCurrent Research and Scholarly InterestsMy research interests reside in the field of Neurocritical Care Medicine and stem from my experience developing and directing Stanford's comprehensive Pediatric Neurocritical Care program. I am interested in neuro-prognostication and neuro-monitoring in the pediatric intensive care setting. These interests are integrated clinically to focus on optimal care for pediatric patients with neurologic injury, through specialized nursing and physician care, protocols, and physiologic considerations.
-
Babak Razavi, MD, PhD
Clinical Associate Professor, Adult Neurology
BioDr. Razavi's clinical interests are in medically refractory epilepsies and using high density EEG (electroencephalogram) for better localization of seizure foci. His research areas include using advanced digital signal processing and engineering techniques for analyzing EEG and using seizures as a model for understanding consciousness.
Dr. Razavi is the Founder and Director of DEL - Distributed EEG Lab. DEL's vision is to make EEG easy as 1, 2, 3. We turn complexity into simplicity. We are distributed in time and space. DEL was founded in the spirit of cloud computing, networking, and the notion that research in collaboration is more exciting and fruitful than in isolation. Everyone contributes - no matter how small; everyone wins - no matter how big. It was inspired by the mentorship of Dr. Kimford Meador and Dr. Robert Fisher. All you need is access to a computer and the internet.
DEL is the ideal collaborative environment for students (undergraduate and graduate) and faculty who would like to: (1) apply ready-to-use advanced analytical techniques to test specific hypotheses in cognition, neuroscience and epilepsy, and (2) develop and test new algorithms for analyzing EEG and other biological signals. -
Lawrence Recht, MD
Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsOur laboratory focuses on two interrelated projects: (1) assessment of glioma development within the framework of the multistage model of carcinogenesis through utilization of the rodent model of ENU neurocarcinogenesis; and (2) assessment of stem cell specification and pluripotency using an embryonic stem cell model system in which neural differentiation is induced.
-
Richard J. Reimer, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
Current Research and Scholarly InterestsReimer Lab interests
A primary interest of our lab is to understand how nerve cells make and recycle neurotransmitters, the small molecules that they use to communicate with each other. In better defining these processes we hope to achieve our long-term goal of identifying novel sites for treatment of diseases such as epilepsy and Parkinson Disease. In our studies on neurotransmitter metabolism we have focused our efforts on transporters, a functional class of proteins that move neurotransmitters and other small molecules across membranes in cells. Transporters have many characteristics that make them excellent pharmacological targets, and not surprisingly some of the most effective treatments for neuropsychiatric disorders are directed at transporters. We are specifically focusing on two groups of transporters vesicular neurotransmitter transporters that package neurotransmitters into vesicles for release, and glutamine transporters that shuttle glutamine, a precursor for two major neurotransmitters glutamate and GABA, to neurons from glia, the supporting cells that surround them. We are pursuing these goals through molecular and biochemical studies, and, in collaboration with the Huguenard and Prince labs, through physiological and biosensor based imaging studies to better understand how pharmacological targeting of these molecules will influence neurological disorders.
A second interest of our lab is to define mechanism underlying the pathology of lysosomal storage disorders. Lysosomes are membrane bound acidic intracellular organelles filled with hydrolytic enzymes that normally function as recycling centers within cells by breaking down damaged cellular macromolecules. Several degenerative diseases designated as lysosomal storage disorders (LSDs) are associated with the accumulation of material within lysosomes. Tay-Sachs disease, Neimann-Pick disease and Gaucher disease are some of the more common LSDs. For reasons that remain incompletely understood, these diseases often affect the nervous system out of proportion to other organs. As a model for LSDs we are studying the lysosomal free sialic acid storage disorders. These diseases are the result of a defect in transport of sialic acid across lysosomal membranes and are associated with mutations in the gene encoding the sialic acid transporter sialin. We are using molecular, genetic and biochemical approaches to better define the normal function of sialin and to determine how loss of sialin function leads to neurodevelopmental defects and neurodegeneration associated with the lysosomal free sialic acid storage disorders. -
Eric Rider, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Rider is a board-certified, fellowship-trained neuromuscular neurologist with the Neuromuscular Program at the Stanford Neuroscience Health Center. He is also a clinical assistant professor in the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Rider specializes in treating neuromuscular disease, including motor neuron disease, disorders of the neuromuscular junction, peripheral and focal neuropathies, as well as other acquired or genetic conditions that cause muscular deterioration, muscle weakness, and nerve damage. He practices both Comprehensive Neurology and Neuromuscular Medicine in Palo Alto and Emeryville.
Dr. Rider earned his medical degree at the University of California, San Francisco and completed residency at Stanford. He also completed fellowship training in Neuromuscular Medicine at UCSF. He has a passion for teaching neurology to students and patients. He was awarded the Fishers and Dunn teaching award for medical student teaching as a resident.
Dr. Rider is a member of the American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine. -
Lucia Rivera Lara, MD, MPH
Clinical Professor, Adult Neurology
BioDr. Rivera Lara is a Clinical Professor at Stanford University School of Medicine, where she is highly regarded for her clinical excellence and dedication to education and research in the field of neurology. She treats patients suffering from strokes, cerebral hemorrhages, and seizures. Dr. Rivera Lara completed her residency in Neurology at the University of Massachusetts and her fellowship in Neurocritical Care at Johns Hopkins University. During her fellowship, she received a Research Award from the American Academy of Neurology/American Brain Foundation.
Dr. Rivera Lara joined the faculty at Johns Hopkins University in 2014, initially as an Instructor and later as an Assistant Professor, working in the neurocritical care unit and the Neurology inpatient and consult service. She earned her Master’s in Public Health from the Johns Hopkins Bloomberg School of Public Health in 2017, which equipped her with a broader perspective on research and global health.
Today, her research is at the forefront of addressing critical issues in neurology. Dr. Rivera Lara focuses on developing neuromonitoring algorithms aimed at optimizing cerebral blood flow delivery for patients with acute brain injuries, with the goal of preventing cerebral ischemia and subsequent complications. By studying cerebral autoregulation and employing multimodal brain monitoring techniques, she aims to mitigate secondary injuries, ultimately helping to reduce cognitive impairment and decrease disability in these vulnerable patients. Her findings have been published in journals including Critical Care Medicine, Neurocritical Care, Stroke, Seizure, the Journal of Neurosurgery and Anesthesiology, and JAMA, and she has presented at the International Stroke Conference, the Critical Care Conference, and at meetings of the American Academy of Neurology and the Neurocritical Care Society.
Dr. Rivera Lara is a Global Health Faculty Fellow at Stanford University for her work on neurological health disparities in Latin America. She founded "Conferencias de Cuidado Neurocritico," which are bimonthly lectures on Neurocritical Care Emergencies and Stroke Management conducted in Spanish via Zoom, attended by residents, fellows, and intensivists from Latin American countries such as Mexico, Guatemala, Colombia, Paraguay, Bolivia, Argentina, and others. -
Zachary T. Roberts, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Zach Roberts is a board-certified neurologist and epileptologist with Stanford Health Care’s Comprehensive Neurology Program. He is also a clinical assistant professor in the Department of Neurology & Neurological Sciences. He completed two years of epilepsy fellowship training at New York University Langone Health where he gained extensive experience using neuromodulatory devices and managing epilepsy that is difficult to treat. Prior to this fellowship, he completed his neurology residency at the University of Pennsylvania.
Dr. Roberts specializes in caring for patients with epilepsy. He creates personalized, comprehensive care plans tailored to each patient’s unique needs. He is skilled in the use of neuromodulatory devices for treating epilepsy, including vagal nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS). His additional clinical interests include the interpretation of electroencephalography (EEG) studies as well as the treatment of sleep disorders.
Dr. Roberts has had a passion for medical education throughout his training as a doctor. He has taught and created content related to neurology and epilepsy for medical students, residents, fellows, and patients. He has designed a simulation-based learning module for the treatment of prolonged seizures and lectured on neurology for a physician assistant program in Pennsylvania. He is dedicated to advancing the knowledge of both his peers and patients.
His research interests include quality improvement as well as using technology to aid health care delivery—both in treating epilepsy and in the field of neurology. Dr. Roberts’ work has been featured on posters presented at national and international conferences. He has also published a peer-reviewed journal article on doctors’ experiences with teleneurology in Telemedicine and e-Health.
Dr. Roberts is an active member of the American Academy of Neurology, the American Medical Association, and the American Epilepsy Society. -
Katherine Jane Ryan
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
Clinical Assistant Professor (By courtesy), Adult NeurologyCurrent Research and Scholarly InterestsDr. Katherine “Katie” Ryan is a pediatric neuro-oncologist whose research focuses on developing and translating cellular immunotherapies for children with malignant brain tumors. She leads the first-in-human trial of GPC2-directed CAR T cells for CNS Embryonal Tumors. As a member of Stanford Children’s world-renowned pediatric brain tumor team, she diagnoses and treats children with CNS tumors while advancing innovative trial design, intracerebroventricular delivery, and correlative science.
